Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SANUWAVE Health (SNWV) Return on Sales (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Return on Sales for 9 consecutive years, with 0.38% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales fell 9.0% to 0.38% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.38%, a 17.0% increase, with the full-year FY2024 number at 0.17%, up 19.0% from a year prior.
  • Return on Sales was 0.38% for Q3 2025 at SANUWAVE Health, up from 68.52% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.47% in Q3 2024 to a low of 68.52% in Q2 2025.
  • A 3-year average of 8.82% and a median of 0.11% in 2025 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: soared 652bps in 2024, then tumbled -6870bps in 2025.
  • SANUWAVE Health's Return on Sales stood at 6.34% in 2023, then surged by 107bps to 0.45% in 2024, then fell by -15bps to 0.38% in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Return on Sales are 0.38% (Q3 2025), 68.52% (Q2 2025), and 0.11% (Q1 2025).